Bacterial conjunctivitis, often called "pink eye", is a common eye infection caused by bacteria. It typically presents with symptoms like thick yellow discharge, redness, and eyelid sticking. While many cases clear up on their own, antibiotics can speed up recovery and reduce complications. Here’s a quick breakdown of treatment options:
- Fluoroquinolones (e.g., besifloxacin, moxifloxacin): Highly effective, especially for severe infections. Besifloxacin stands out for its broad bacterial coverage and low resistance rates.
- Polymyxin B/Trimethoprim (Polytrim): A solid choice for mild to moderate cases, especially in children. It’s effective against common bacteria but less so for MRSA.
- Ointments (e.g., erythromycin): Ideal for children and infants due to ease of application. Provides longer coverage but may cause temporary blurred vision.
- Observation: Mild cases often resolve naturally within 4–9 days. Supportive care like artificial tears and compresses can help.
- Systemic Antibiotics: Necessary for severe infections, such as those caused by Neisseria gonorrhoeae or Chlamydia trachomatis.
Each treatment has its pros and cons, and the choice depends on the severity of the infection, patient age, and specific needs. Severe symptoms like vision changes or significant pain require immediate medical attention.
WHAT CAUSES PINK EYE & HOW TO TREAT PINK EYE: youtube eye doctor explains conjunctivitis
sbb-itb-929a4e2
1. Fluoroquinolones (Ciprofloxacin, Moxifloxacin, Besifloxacin)
Fluoroquinolones are a go-to option for treating bacterial conjunctivitis due to their ability to target both gram-positive and gram-negative bacteria. This group includes older medications like ciprofloxacin and newer ones such as moxifloxacin and besifloxacin. However, bacterial resistance has become a growing issue. For instance, ciprofloxacin resistance among gram-positive bacteria rose from 11.7% to 35.6% over a decade. Resistance is particularly high in MRSA-related eye infections, with rates of 94% for ciprofloxacin and 68% for moxifloxacin.
Effectiveness
Besifloxacin has emerged as a standout option, with bacterial eradication rates surpassing 90% and clinical resolution rates reaching 70% or more by day five. In direct comparisons, besifloxacin achieved a 93.3% eradication rate, slightly higher than moxifloxacin’s 91.1%. Unlike other fluoroquinolones, besifloxacin was specifically developed for eye conditions, avoiding resistance linked to systemic treatments. It also demonstrates 8 to 128 times greater potency against ciprofloxacin-resistant MRSA and MRSE strains compared to other fluoroquinolones.
Patient Suitability
Choosing the right treatment depends on factors like the severity of the infection, patient age, and tolerance to the medication. Older fluoroquinolones, such as ciprofloxacin, are effective for less severe infections, while newer options like besifloxacin are better suited for more serious cases. Besifloxacin is approved for use in both children and adults, making it a flexible choice. For patients sensitive to preservatives, moxifloxacin (Vigamox) offers a preservative-free formula. Ciprofloxacin remains the best option against Pseudomonas aeruginosa, while levofloxacin is particularly effective against Streptococcus pneumoniae.
Application Method
Besifloxacin is typically applied as one drop three times daily for five days or twice daily for three days. It uses a mucoadhesive polymer called DuraSite, which extends the medication’s presence on the eye’s surface. This results in a mean residence time of 4.7 hours in the conjunctiva, compared to 3.0 hours for moxifloxacin. Older fluoroquinolones often require more intensive dosing, starting with applications every two hours for the first day or two, followed by four times daily.
Side Effects
Topical fluoroquinolones are generally well-tolerated, with fewer side effects than placebo (Risk Ratio 0.7). The most common issue with besifloxacin is mild conjunctival redness, affecting just 2% of users. Other minor side effects, such as blurred vision, eye pain, irritation, itching, and headaches, occur in only 1% to 2% of cases. Because these medications are applied directly to the eye, systemic absorption is minimal (less than 0.5 ng/mL), virtually eliminating the risk of systemic side effects. One exception is ciprofloxacin, which may occasionally leave white crystalline deposits in corneal ulcers, potentially causing confusion with infection.
2. Polymyxin B/Trimethoprim and Sulfacetamide
Polytrim (Polymyxin B/Trimethoprim) stands out with its dual-action approach to treating bacterial conjunctivitis. It combines Polymyxin B, which disrupts bacterial cell membranes, and Trimethoprim, which halts protein synthesis. This combination makes it effective against a variety of pathogens, including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa.
Effectiveness
Clinical data reveals that about 95% of patients treated with Polytrim see improvement or complete resolution of symptoms within 7 days, with cure rates around 84% between days 2 and 7. While these results are comparable to other antibiotics like gentamicin and sulfacetamide, newer fluoroquinolones such as moxifloxacin may work faster. For instance, one study reported symptom resolution in 81% of patients within 48 hours using moxifloxacin, compared to 44% with Polytrim. Additionally, Polytrim matches the effectiveness of neomycin-polymyxin B-gramicidin (Neosporin) but tends to cause fewer side effects. These findings help clinicians decide when Polytrim is the right choice based on patient needs.
Patient Suitability
Polytrim is a great option for children aged 2 months and older, as it effectively treats common pediatric pathogens like Haemophilus influenzae. It’s also safe for breastfeeding mothers and elderly patients. However, it’s not suitable for severe infections like gonococcal or chlamydial conjunctivitis, which require systemic antibiotics. Its limited effectiveness against MRSA means alternative treatments like vancomycin may be necessary in those cases. Patients with allergies to any of its ingredients should avoid using this medication. When prescribed appropriately, Polytrim serves specific patient groups effectively.
Application Method
The recommended dosage is one drop in the affected eye(s) every 3 to 4 hours for 7 to 10 days. To prevent contamination, wash hands thoroughly before and after use and avoid touching the applicator tip to any surface. Contact lenses should not be worn during treatment or while symptoms persist. If your doctor approves resuming lens use, wait at least 15 minutes after applying the drops. The systemic absorption of the medication is minimal, with approximately 0.03 mcg/mL for trimethoprim and 1 unit/mL for polymyxin B.
Side Effects
Common side effects include local irritation such as redness, burning, stinging, and itching. Some patients may also experience eyelid swelling, tearing, rashes around the eyes, and intense itching. Less frequent side effects include blurred vision and increased sensitivity. In studies involving children, 62% of patients reported finding the treatment "very comfortable", while 27% rated it as "moderately comfortable". The drops should be stored at room temperature (59°–77°F) and protected from light. If symptoms don’t improve within 3 to 4 days, or if severe pain or vision loss occurs, seek medical attention promptly.
These attributes make Polytrim a strong contender when choosing a treatment plan for bacterial conjunctivitis.
3. Ointment-Based Treatments (Erythromycin, Bacitracin/Polymyxin B)
Ointment treatments like erythromycin and bacitracin/polymyxin B are a reliable option for bacterial conjunctivitis. Unlike drops, ointments stay on the eye longer, providing extended coverage against bacteria and making them a practical choice in treatment plans.
Effectiveness
Polymyxin B–bacitracin ointment shows a 62% clinical cure rate and 71% bacterial eradication within 3–5 days, compared to only 28% for placebo. Erythromycin achieves an impressive 96% clinical cure rate for neonatal chlamydial conjunctivitis. According to the American Academy of Ophthalmology, "No clinical evidence suggests superiority of any particular agent for mild cases".
Erythromycin and bacitracin target gram-positive bacteria, while combination ointments like polymyxin B/bacitracin expand coverage to gram-negative bacteria. Severe infections or contact lens wearers often require fluoroquinolone drops due to their stronger potency and ability to tackle pathogens like Pseudomonas. These efficacy rates help determine when ointments are the best option for different patient needs.
Patient Suitability
Ointments are particularly helpful for children since they resist being washed away by tears and are easier to apply. Erythromycin ointment (0.5%) is the go-to for preventing neonatal eye infections caused by N. gonorrhoeae or Chlamydia. Bacitracin works well for managing blepharitis when applied to the eyelid margins after cleaning away debris.
Erythromycin is often the most budget-friendly choice while still being effective. However, the temporary blurred vision caused by ointments – lasting around 20 minutes – may make them less practical for adults who need clear vision immediately. Contact lens users should avoid ointments during symptomatic periods, opting instead for fluoroquinolone drops.
Application Method
- Squeeze a 1/2-inch ribbon of ointment into the lower conjunctival sac.
- Tilt your head back, gently pull down the lower eyelid to create a pocket, and apply the ointment carefully without letting the tube tip touch your eye or skin.
- Close your eyes gently for 1–2 minutes to allow absorption.
- Use a clean tissue to wipe away any excess ointment from your eyelids or lashes.
| Medication | Common Strength | Typical Dosage | Primary Use |
|---|---|---|---|
| Erythromycin | 0.5% (5 mg/g) | 1 cm ribbon up to 6× daily | Mild cases, neonatal prophylaxis |
| Bacitracin | 500 U/g | 1 cm ribbon 1–3× daily | Gram-positive infections, blepharitis |
| Polymyxin B/Bacitracin | 10,000 U / 500 U/g | Apply every 3–4 hours | Broad-spectrum coverage |
Always wash your hands before and after applying the ointment. Continue treatment for 5–7 days or until symptoms resolve, but complete the full course to reduce the risk of recurrence or antibiotic resistance. Watch for any side effects during treatment.
Side Effects
The most common side effect is temporary blurred vision. Other possible reactions include burning, redness, itching, swelling, or slower healing. Serious symptoms, such as intense pain, worsening discharge, rash, hives, or breathing difficulty, require immediate medical attention. If symptoms don’t improve within 3–4 days, consult your eye care provider.
Store ointments at room temperature (59°–77°F) and away from direct light or heat. Never freeze them. To avoid spreading infection, don’t share eye products, towels, or washcloths.
4. Observation and Systemic Antibiotics
Mild bacterial conjunctivitis often clears up on its own without the need for medication. The American Academy of Ophthalmology advises against routine antibiotic use for acute conjunctivitis because most cases resolve naturally. However, severe infections – such as those caused by Neisseria gonorrhoeae or Chlamydia trachomatis – require immediate systemic antibiotics to prevent complications. Treatment decisions hinge on the severity of the infection.
Effectiveness
For uncomplicated cases, around 55% of patients recover within 4–9 days without antibiotics. Using topical antibiotics can increase recovery rates to 68.2%. The Centers for Disease Control and Prevention (CDC) notes that mild bacterial conjunctivitis typically clears up in 2 to 5 days without treatment, although full recovery may take up to two weeks.
In high-risk situations, systemic antibiotics are crucial to avoiding severe complications like corneal perforation or meningitis. For instance, gonococcal conjunctivitis is treated with a single intramuscular dose of ceftriaxone (1 g) along with a 1 g oral dose of azithromycin. Chlamydial conjunctivitis is addressed with either a single 1 g dose of azithromycin or a course of doxycycline.
Patient Suitability
Observation is a practical approach for adults and children with mild symptoms, such as slight redness and minimal discharge, as long as there are no changes in vision or severe pain. Supportive care – like cold or warm compres